The Japan Times A nonprofit group said Friday it was launching a project to comb the catalogues of some of Japan's biggest drug companies in the hunt for treatments fo...
Manawatu Standard The report says that in Europe, the rapid emergence of new drugs had prompted a variety of innovative legal responses, and the situation continued to evolve. It noted that since 2009, at least seven European countries had introduced a control measure ...
The Australian The plan involves cutting costs by $12 million a year and seeking to partner with a larger pharmaceutical company to further develop its drug Bronchitol for cystic fibrosis in the US and bronchiectasis worldwide. Up to 55 staff ... Pharmaxis chief ...
